Impact of portal vein embolization on expression of cancer stem cell markers in regenerated liver and colorectal liver metastases

References

• Tai MH, Chang CC, Kiupel M, Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26:495–502
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001;414:105–11
   PubMed Web of Science ®Google Scholar
• Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Cancer 2003;3:895–901
   PubMedGoogle Scholar
• Abate-Shen C. Homeobox genes and cancer: new OCTaves for and old tune. Cancer Cell 2003;4:329–30
   PubMedGoogle Scholar
• Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose dependent oncogenic fate determinant. Cancer Cell 2003;4:361–70
   PubMedGoogle Scholar
• Monk M, Holding C. Human genes re-expressed in cancer cells. Oncogene 2001;20:8085–91
   PubMed Web of Science ®Google Scholar
• Resce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001;19:271–8
   PubMedGoogle Scholar
• Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes Oct4, NANOG, STELLAR and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005;104:2255–65
   PubMed Web of Science ®Google Scholar
• Petersen BE, Bowen WC, Patrene KD, Bone marrow as a potential source of hepatic oval cells. Science 1999;290:1779–82
   Google Scholar
• Köbel M, Weichert W, Crüwell K, Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004;445:456–64
   PubMedGoogle Scholar
• Hart AH, Hartley L, Parker K, The pluripotency homeobox gene NANOG is expressed in human germ cell tumours. Cancer 2005;104:2092–8
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernadez A, Prospective identification of tumourigenic breast cancer cells. PNAS 2003;100:3983–8
   PubMed Web of Science ®Google Scholar
• Wielenga VJM, Heider KH, Offerhaus GJ, Expression of CD44 variant proteins in human colorectal cancer is related to tumour progression. Cancer Res 1993;53:4754–6
   PubMed Web of Science ®Google Scholar
• Cheng L. Establishing a germ cell origin for metastatic tumours using Oct4 immunohistochemistry. Cancer 2004;9:2006–10
   Google Scholar
• Yin S, Li J, Hu C, CD133 positive hepatocellular carcinoma cells possess high capacity for tumourigenicity. Int J Cancer 2007;120:1444–50
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111–15
   PubMed Web of Science ®Google Scholar
• Piechaczek C. CD133. J Biol Regul Homeost Agents 2001;15:101–2
   PubMed Web of Science ®Google Scholar
• Mackay CR, Terpe HJ, Stauder R, Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994;124:71–82
   PubMed Web of Science ®Google Scholar
• Suo G, Han J, Wang X, Oct4 pseudo genes are transcribed in cancer. Biochem Biophys Res Commun 2005;337:1047–51
   PubMed Web of Science ®Google Scholar
• Jackson PA, Green MA, Pouli A, Relation between stage, grade, proliferation, and expression of p53 and CD44 in the adenomas and carcinomas of the colorectum. J Clin Pathol 1995;48:1098–101
   PubMedGoogle Scholar
• Yamakado K, Takeda K, Matsumura K, Regeneration of the un-embolised liver parenchyma following portal vein embolisation. J Hepatol 1997;27:871–80
   PubMedGoogle Scholar
• Madoff DC, Hicks ME, Vauthey JN, Transhepatic portal vein embolisation: anatomy, indications and technical considerations. Radiographics 2002;22:1063–76
   PubMed Web of Science ®Google Scholar
• Kokudo N, Tada K, Seki M, Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolisation. Hepatology 2001;34:267–72
   PubMedGoogle Scholar
• Abdalla EK, Barnett CC, Doherty D, Extended hepatectomy in patients with hepatobiliary malignancies with and without portal vein embolisation. Arch Surg 2002;137:675–81
   PubMedGoogle Scholar
• Wakabayashi H, Ishimura K, Okano K, Is preoperative poral vein embolisation effective in improving prognosis after major hepatic resuscitation in patients with advanced-stage hepatocellular carcinoma? Cancer 2001;92:2384–90
   PubMedGoogle Scholar
• am Esch JS II, Knoefel WT, Klein M, Portal application of autologous CD133+ bone marrow stem cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23:463–70
   PubMed Web of Science ®Google Scholar
• Fürst G, Schulte am Esch J, Poll LW, Portal vein embolisation and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171–9
   PubMed Web of Science ®Google Scholar